U.S. News Best Hospitals voting is open: Vote now on doximity.com
America’s premier transplant program features world-renowned physicians, better survival rates, and innovative approaches.
The transplant program at NewYork-Presbyterian, Columbia, and Weill Cornell Medicine is among the longest established and most experienced program in the country. Due to their experience and expertise, our physicians can confidently care for some of the most complex transplants, including multi-organ transplants. Patients come to us from across the country and around the world for better outcomes and innovative procedures that allow for quicker access to transplants and also quicker recovery.
Columbia Physicians Examine the Safety and Efficacy of Tocilizumab for the Treatment of Severe COVID-19 Infection
Researchers at NewYork-Presbyterian/Columbia examine the safety and efficacy of tocilizumab for the treatment of severe COVID-19 infection in 29 solid organ transplant recipients and 29 matched controls.
Liver Paired Exchange Program
As the U.S. continues to face a major organ shortage, liver experts consider innovative methods to increase the number of liver allografts. A liver paired exchange program could expand the pool for patients with ABO incompatible and size mismatched living donors.
COVID-19 Lung Transplant Recipient Case Series
In the largest, single-center retrospective case series of lung transplant recipients infected with COVID-19 to date, the Lung Transplant Program at NewYork-Presbyterian/Columbia shares its experience.
COVID-19 Infection in Patients Waitlisted for Kidney Transplantation and Kidney Transplant Recipients
Researchers at NewYork-Presbyterian/Weill Cornell Medicine examined the health outcomes of 56 patients on the waitlist for kidney transplantation and 80 kidney transplant recipients infected with COVID-19.
COVID-19 Infection in Kidney Allograft Recipients
In a retrospective chart review of 54 kidney transplant recipients infected with COVID-19, researchers at NewYork-Presbyterian/Weill Cornell Medicine describe their strategy for systematic triage and management techniques for immunosuppressive therapies.
COVID-19 All Solid Organ Transplant Recipient Cohort Study
In a collaborative effort between NewYork-Presbyterian/Columbia and NewYork-Presbyterian/Weill Cornell Medicine, researchers share their experience across all solid organ transplants—lung, kidney, heart, and dual organ—during a 3-week period at the height of the outbreak in New York City.
COVID-19 Experience of NewYork-Presbyterian/Columbia’s Kidney Transplant Program
In a series of 6 recently published papers, NewYork-Presbyterian/Columbia shared their experience to help other centers around the country who are undergoing a pandemic surge
Lung Transplantation: Decades of Experience and Expertise
Since the inception of the program nearly two decades ago, the Lung Transplantation Program at NewYork-Presbyterian/Columbia has performed more than 1000 lung transplants with survival rates that far surpass national averages.
Management of Heart Transplant Recipients Infected With SARS-COV2
Heart transplant recipients with COVID-19 are at high risk for severe complications. The researchers, led by Nir Uriel, MD, MSc, discuss implications for the management of SARS-COV2, given the need for immunosuppression in this patient population.
Living Donor Liver Transplant
As one of 20 centers in the United States who perform more than 20 living donor liver transplants per year, NewYork-Presbyterian is helping to expand the donor pool by advocating for living donations.